Omega-3 polyunsaturated fatty acids (n‐3-PUFAs), mainly eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA), may improve or prevent some psychiatric and …

Omega-3 polyunsaturated fatty acids (PUFAs) exhibit neuroprotective properties and
represent a potential treatment for a variety of neurodegenerative and neurological …

Brain lipids contain a high proportion of polyunsaturated fatty acids (PUFA), which are a
main component of cell membranes. Omega-3 (ω-3) PUFA eicosapentaeoic acid (EPA) and …

Alzheimer disease (AD) is becoming one of the most prevalent neurodegenerative
conditions worldwide. Although the disease progression is becoming better understood …

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can exert antidepressant,
anti-inflammatory and neuroprotective properties, but the exact molecular mechanism …

The central nervous system is highly enriched in long-chain polyunsaturated fatty acid
(PUFA) of the omega-6 and omega-3 series. The presence of these fatty acids as structural …

Neurodegenerative diseases are characterized by neuroinflammation, neuronal depletion
and oxidative stress. They coincide with subtle chronic or flaring inflammation, sometimes …

Among omega-3 polyunsaturated fatty acids (PUFAs), docosahexaenoic acid (DHA, 22: 6n-
3) is important for adequate brain development and cognition. DHA is highly concentrated in …

The current rise in the prevalence of Alzheimer's disease (AD) is unfortunately not matched
by new treatment options. In the last 10 years, epidemiological, preclinical and clinical data …

Omega-(n)-3 polyunsaturated fatty acids (PUFAs), including docosahexaenoic acid (DHA)
and eicosapentaenoic acid (EPA) are major components of neuronal membranes and have …